Incontinence: Introduction and Prevalence




© Springer International Publishing AG 2017
Ajay Singla and Craig Comiter (eds.)Post-Prostatectomy Incontinence10.1007/978-3-319-55829-5_1


Post-prostatectomy Incontinence: Introduction and Prevalence



Nirmish Singla1 and Allen F. Morey 


(1)
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA

 



 

Allen F. Morey



Keywords
Post-prostatectomy incontinencePrevalenceQuality of lifeRisk factorsPatient evaluationArtificial urinary sphincterMale sling



Introduction


Prostate cancer is the most frequently diagnosed malignancy in men, with an estimated 220,800 new diagnoses in the United States in 2015 [1]. Approximately 40% of men with localized prostate cancer elect to undergo radical prostatectomy [2]. While stress urinary incontinence (SUI) is almost universally evident immediately following prostatectomy, the severity and degree of recovery are variable. Reported rates of persistent and bothersome urinary leakage following prostatectomy, or post-prostatectomy incontinence (PPI), range anywhere from 5 to 72% [3], though this variability is largely due to the absence of a strict definition for PPI.

With the emergence of minimally invasive technologies, robotic approaches to performing prostatectomy have become widely popularized. PPI nonetheless remains an issue, with a reported incidence of 4–31% in robotic cases, versus 7–40% in open cases [4]. Other series have reported PPI rates of <10% after robotic prostatectomy, with improvement seen over the first 24 months following surgery [5]. Although refinement in surgical techniques has helped reduce the incidence of PPI [6], the overall prevalence continues to rise due to an increase in the total number of prostatectomies performed worldwide.

Indeed, PPI can have a profound impact on the quality of life in patients following treatment for prostate cancer [7]. Approximately half of patients seek some treatment for PPI [8], and 6–9% are bothered enough to elect for surgical management [714]. In a recent pilot study that prospectively evaluated a novel grading scale for the evaluation of men with PPI, we found that the median duration from the time of radical prostatectomy to anti-incontinence surgery was an alarming 5.4 years (range 1–20 years) [15] despite traditional recommendations to defer surgical intervention for PPI by only a year after PPI [16]. Hence early recognition of this issue is of paramount importance.


Risk Factors and Pathophysiology


Several risk factors have been postulated to increase the likelihood of developing incontinence following prostatectomy. Broadly, these can be categorized into patient-related factors (such as preoperative voiding function, patient anatomy, and comorbidities) and intraoperative technique. A more extensive discussion of the underlying pathophysiology of PPI is provided elsewhere in this textbook.


Patient Factors


Preexisting urinary incontinence or voiding dysfunction increases the likelihood of developing PPI. As most cases of SUI in males tend to arise following prostatectomy, presurgical SUI is relatively uncommon. In a recent study on 1000 adult men, urinary incontinence was prevalent in only 5.4%, of whom approximately one-fourth (26%) suffered from isolated SUI [17]. These men presumptively suffer from baseline intrinsic sphincter deficiency (ISD), which manifests as clinical SUI or low maximal urethral closure pressure on urodynamics [18, 19]. The intrinsic component of the urethral sphincter appears to be responsible for passive continence, while the extrinsic component plays a more substantial role in active continence [20]. Membranous urethral length, including both anatomic length based on magnetic resonance imaging (MRI) and functional length shown on urodynamic studies, has been shown to be directly associated with continence rates [19, 2123]. Preserving the functional integrity of the distal urethral sphincter mechanism is thus necessary for maintaining postoperative continence.

Other functional or anatomic issues with either the bladder or the outlet can also predispose patients to developing PPI. Examples of such risk factors include neurogenic detrusor overactivity, as seen in Parkinson’s disease or other neurologic insult [24] larger prostate volume [25], and the presence of an anatomic stricture [26, 27] or post-prostatectomy anastomotic stricture [28, 29] causing outlet obstruction. ISD tends to be the most common underlying etiology in PPI, while isolated bladder dysfunction occurs in only less than 10% of cases [28, 29]; however, both sphincter and bladder dysfunction can coexist in at least one-third of incontinent patients [28, 29]. Bladder dysfunction can also occur de novo following prostatectomy [30, 31].

Advancing age has also been shown to be an independent risk factor for the development of PPI [14, 3237]. Older men have a greater likelihood of requiring eventual artificial urinary sphincter (AUS) for severe PPI [38]. Strasser et al. hypothesize this age-related phenomenon to be related to a progressive reduction in striated muscle cells within the external urinary sphincter with increasing age [39]. Body mass index (BMI) is also associated with increased PPI rates, reportedly three times higher for patients with BMI >30 kg/m2 compared to those with lower BMI [40]. Obesity may also present technical challenges, such as difficulty with performing the vesicourethral anastomosis, and often coexists with other comorbidities such as diabetes and vascular disease [41, 42]. Finally, patients who are undergoing salvage prostatectomy following prior radiotherapy or cryotherapy tend to experience higher rates of PPI [43] and greater likelihood of needing AUS implantation [4447].


Intraoperative Factors


Postoperative continence outcomes may also be dictated in part by technical features intraoperatively. Most cases of PPI are likely a direct result of surgical injury to the native urinary sphincteric mechanisms [13], particularly the intrinsic component [2830]. Bladder denervation during prostatectomy may also contribute to PPI due to the resultant impairment in detrusor contractility and poor bladder compliance.

Several studies have shown that bilateral nerve-sparing techniques may help preserve continence [19, 4850], though this is debated [51, 52]. Bladder neck preservation may improve early return of continence at 3 months [53], though its effect on continence status at 6 and 12 months may not be significant [54, 55]. Other surgical maneuvers such as sparing of seminal vesicles, urethral suspension, and bladder neck mucosal eversion have also been suggested to reduce PPI rates [21, 36, 48]. Surgeon experience may play a role as well [56]. With respect to surgical approach, no significant differences in continence rates have been demonstrated between perineal and retropubic approaches [57, 58] or among open, laparoscopic, and robotic approaches [9, 11, 5961].


Evaluation and Management


As the evaluation of patients with PPI and options for management will be discussed more extensively later in this textbook, we provide here an introductory overview.


Evaluation


The primary goal when approaching patients with PPI is to discern the degree of subjective bother and severity of incontinence in order to appropriately direct therapy. Evaluation of PPI patients should begin with a comprehensive history, including the onset, duration, type, and severity of incontinence, along with precipitating events. Subjective bother from incontinence can be discerned by assessing its impact on daily activities. A history of radiation increases the probability that detrusor overactivity or poor compliance may exist. A voiding diary can be helpful to quantify the fluid intake and functional bladder capacity [62]. Quantifying the severity of leakage based on the number of pads used per day [63, 64] or objectively using pad weights [65] or ultrasonic post-void residual volumes to assess bladder emptying [66] can be helpful to facilitate treatment decision-making.

Physical examination is an important component that should not be overlooked when evaluating PPI patients. In our clinical experience, we have found the standing cough test (SCT), introduced nearly 20 years ago by Kowalczyk et al. [67], to be a useful method to easily and reproducibly assess the severity of male SUI. From our experience in hundreds of PPI patients over more than a decade of focused clinical practice in prosthetic urology, we have recognized several distinct patterns of leakage commonly observed during routine implementation of the SCT. We recently attempted to standardize those leakage patterns and correlate them with other patient-reported indicators of condition severity and clinical outcomes [15]. In our pilot study, we reported a strong concordance (r = 0.74) between SCT patterns and patient-reported pad-per-day, which has been previously shown to correlate strongly with pad weights [68]. In addition to the SCT, neurological evaluation should be performed to assess the S2-S4 spinal segments, including anal sphincter tone, perineal sensation in the S2-S4 segments, and the bulbocavernosus reflex. Abdominal examination is performed to assess for prior scars and to detect a potentially distended bladder with overflow incontinence.

Office cystoscopy can be conducted to evaluate the integrity of the external urinary sphincter and bladder neck. Endoscopic evidence of urethral coaptation may suggest the degree of sphincter insufficiency. Patients with obstructive symptoms ideally should also be evaluated with cystoscopy before any surgical treatment to rule out anastomotic strictures [69]. Multichannel urodynamic testing may provide some information about bladder contractility [70] and Valsalva abdominal leak point pressure (ALPP) measurement to assess sphincter weakness [71]; however, its routine use in PPI appears to be of limited value, demonstrating poor correlation with anti-incontinence surgical outcomes [72, 73].


Management


A range of options exists for managing PPI. A trial of conservative measures is certainly worth consideration prior to surgical treatment. Examples of effective nonsurgical methods include pelvic floor exercises (Kegel exercises) [74, 75] and behavioral modifications, such as limiting fluid intake or bladder irritants such as alcohol and caffeine [76]. Additional approaches such as biofeedback, pelvic floor stimulation, pharmacotherapy, and urethral bulking agents have also been studied, though with limited evidence to support their clinical utility in the PPI setting [69].

Surgical intervention for PPI is traditionally deferred for at least 1 year after prostatectomy [16], though in select cases it may be reasonable to consider surgical management even earlier. The AUS presently remains the gold standard for PPI treatment, though in more recent years, the male urethral sling has emerged as an attractive, less complex alternative. While slings can be effective for the management of mild-to-moderate PPI, more severe PPI is better managed with AUS [77, 78]. Kumar et al. recently demonstrated that patients usually prefer a sling if given the choice, since it takes effect immediately, has lower risk of severe complications, and avoids a mechanical device that may be subject to malfunction or the need for revision [79]. However, several factors must be taken into consideration when counseling patients on their surgical options for PPI [69, 80]. Our recently developed SCT-based grading scale to objectively assess PPI severity appears to help facilitate anti-incontinence surgical procedure selection with favorable patient-reported outcomes [15]. Nonetheless, we still unfortunately lack a standardized algorithm to stratify patients to the ideal treatment for PPI.


References



1.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.CrossRefPubMed


2.

Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004;171(4):1393–401.CrossRefPubMed


3.

Boorjian SA, Eastham JA, Graefen M, Guillonneau B, Karnes RJ, Moul JW, et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol. 2012;61(4):664–75.CrossRefPubMed


4.

Crivellaro S, Morlacco A, Bodo G, Agro EF, Gozzi C, Pistolesi D, et al. Systematic review of surgical treatment of post radical prostatectomy stress urinary incontinence. Neurourol Urodynam. 2015;35:875–81.CrossRef


5.

Tewari AK, Ali A, Metgud S, Theckumparampil N, Srivastava A, Khani F, et al. Functional outcomes following robotic prostatectomy using athermal, traction free risk-stratified grades of nerve sparing. World J Urol. 2013;31(3):471–80.CrossRefPubMed


6.

Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol. 2004;171(2 Pt 1):703–7. discussion 7-8CrossRefPubMed


7.

Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347(11):790–6.CrossRefPubMed


8.

Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, et al. 5-Year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol. 2008;179(5 Suppl):S40–4.CrossRefPubMed

Oct 14, 2017 | Posted by in UROLOGY | Comments Off on Incontinence: Introduction and Prevalence

Full access? Get Clinical Tree

Get Clinical Tree app for offline access